vs
Side-by-side financial comparison of AMN HEALTHCARE SERVICES INC (AMN) and Natera, Inc. (NTRA). Click either name above to swap in a different company.
AMN HEALTHCARE SERVICES INC is the larger business by last-quarter revenue ($748.2M vs $665.5M, roughly 1.1× Natera, Inc.). Natera, Inc. runs the higher net margin — 7.1% vs -1.0%, a 8.1% gap on every dollar of revenue. On growth, Natera, Inc. posted the faster year-over-year revenue change (39.8% vs 1.8%). AMN HEALTHCARE SERVICES INC produced more free cash flow last quarter ($67.6M vs $37.8M). Over the past eight quarters, Natera, Inc.'s revenue compounded faster (34.5% CAGR vs -4.5%).
AMN Healthcare Services Inc. is a leading US healthcare sector workforce solutions and staffing provider. It offers temporary and permanent placement for nurses, physicians, allied health and other clinical/non-clinical staff, plus workforce management tools and consulting for hospitals, clinics and other medical facilities.
Natera, Inc. is a clinical genetic testing company based in Austin, Texas that specializes in non-invasive, cell-free DNA (cfDNA) testing technology, with a focus on women’s health, cancer, and organ health. Natera’s proprietary technology combines novel molecular biology techniques with a suite of bioinformatics software that allows detection down to a single molecule in a tube of blood. Natera operates CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendment...
AMN vs NTRA — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $748.2M | $665.5M |
| Net Profit | $-7.7M | $47.3M |
| Gross Margin | 26.1% | — |
| Operating Margin | 1.1% | -3.4% |
| Net Margin | -1.0% | 7.1% |
| Revenue YoY | 1.8% | 39.8% |
| Net Profit YoY | 95.9% | 187.9% |
| EPS (diluted) | $-0.19 | $0.36 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $748.2M | $665.5M | ||
| Q3 25 | $634.5M | $592.2M | ||
| Q2 25 | $658.2M | $546.6M | ||
| Q1 25 | $689.5M | $501.8M | ||
| Q4 24 | $734.7M | $476.1M | ||
| Q3 24 | $687.5M | $439.8M | ||
| Q2 24 | $740.7M | $413.4M | ||
| Q1 24 | $820.9M | $367.7M |
| Q4 25 | $-7.7M | $47.3M | ||
| Q3 25 | $29.3M | $-87.5M | ||
| Q2 25 | $-116.2M | $-100.9M | ||
| Q1 25 | $-1.1M | $-66.9M | ||
| Q4 24 | $-187.5M | $-53.8M | ||
| Q3 24 | $7.0M | $-31.6M | ||
| Q2 24 | $16.2M | $-37.5M | ||
| Q1 24 | $17.3M | $-67.6M |
| Q4 25 | 26.1% | — | ||
| Q3 25 | 29.1% | — | ||
| Q2 25 | 29.8% | — | ||
| Q1 25 | 28.7% | — | ||
| Q4 24 | 29.8% | — | ||
| Q3 24 | 31.0% | — | ||
| Q2 24 | 31.0% | — | ||
| Q1 24 | 31.4% | — |
| Q4 25 | 1.1% | -3.4% | ||
| Q3 25 | 7.5% | -16.5% | ||
| Q2 25 | -18.8% | -20.2% | ||
| Q1 25 | 1.8% | -15.8% | ||
| Q4 24 | -27.6% | -13.6% | ||
| Q3 24 | 3.2% | -8.9% | ||
| Q2 24 | 5.1% | -10.6% | ||
| Q1 24 | 4.9% | -20.2% |
| Q4 25 | -1.0% | 7.1% | ||
| Q3 25 | 4.6% | -14.8% | ||
| Q2 25 | -17.7% | -18.5% | ||
| Q1 25 | -0.2% | -13.3% | ||
| Q4 24 | -25.5% | -11.3% | ||
| Q3 24 | 1.0% | -7.2% | ||
| Q2 24 | 2.2% | -9.1% | ||
| Q1 24 | 2.1% | -18.4% |
| Q4 25 | $-0.19 | $0.36 | ||
| Q3 25 | $0.76 | $-0.64 | ||
| Q2 25 | $-3.02 | $-0.74 | ||
| Q1 25 | $-0.03 | $-0.50 | ||
| Q4 24 | $-4.90 | $-0.41 | ||
| Q3 24 | $0.18 | $-0.26 | ||
| Q2 24 | $0.42 | $-0.30 | ||
| Q1 24 | $0.45 | $-0.56 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $34.0M | — |
| Total DebtLower is stronger | $767.1M | — |
| Stockholders' EquityBook value | $642.1M | $1.7B |
| Total Assets | $2.1B | $2.4B |
| Debt / EquityLower = less leverage | 1.19× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $34.0M | — | ||
| Q3 25 | $52.6M | $1.0M | ||
| Q2 25 | $41.5M | $16.0M | ||
| Q1 25 | $55.8M | $17.8M | ||
| Q4 24 | $10.6M | $22.7M | ||
| Q3 24 | $30.6M | $29.5M | ||
| Q2 24 | $48.0M | $90.3M | ||
| Q1 24 | $50.6M | $69.1M |
| Q4 25 | $767.1M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $1.1B | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $642.1M | $1.7B | ||
| Q3 25 | $644.4M | $1.3B | ||
| Q2 25 | $607.6M | $1.2B | ||
| Q1 25 | $715.1M | $1.2B | ||
| Q4 24 | $706.6M | $1.2B | ||
| Q3 24 | $890.7M | $878.5M | ||
| Q2 24 | $876.9M | $836.5M | ||
| Q1 24 | $854.2M | $794.1M |
| Q4 25 | $2.1B | $2.4B | ||
| Q3 25 | $2.1B | $1.8B | ||
| Q2 25 | $2.2B | $1.8B | ||
| Q1 25 | $2.4B | $1.7B | ||
| Q4 24 | $2.4B | $1.7B | ||
| Q3 24 | $2.7B | $1.6B | ||
| Q2 24 | $2.8B | $1.5B | ||
| Q1 24 | $2.9B | $1.5B |
| Q4 25 | 1.19× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 1.49× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $75.6M | $73.9M |
| Free Cash FlowOCF − Capex | $67.6M | $37.8M |
| FCF MarginFCF / Revenue | 9.0% | 5.7% |
| Capex IntensityCapex / Revenue | 1.1% | 5.4% |
| Cash ConversionOCF / Net Profit | — | 1.56× |
| TTM Free Cash FlowTrailing 4 quarters | $233.8M | $109.1M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $75.6M | $73.9M | ||
| Q3 25 | $22.7M | $59.4M | ||
| Q2 25 | $78.5M | $37.6M | ||
| Q1 25 | $92.7M | $44.5M | ||
| Q4 24 | $72.8M | $52.9M | ||
| Q3 24 | $66.7M | $51.8M | ||
| Q2 24 | $99.5M | $4.0M | ||
| Q1 24 | $81.4M | $27.0M |
| Q4 25 | $67.6M | $37.8M | ||
| Q3 25 | $14.8M | $37.0M | ||
| Q2 25 | $68.7M | $11.7M | ||
| Q1 25 | $82.7M | $22.6M | ||
| Q4 24 | $56.6M | $34.8M | ||
| Q3 24 | $47.4M | $35.5M | ||
| Q2 24 | $72.2M | $-7.7M | ||
| Q1 24 | $63.2M | $6.7M |
| Q4 25 | 9.0% | 5.7% | ||
| Q3 25 | 2.3% | 6.2% | ||
| Q2 25 | 10.4% | 2.1% | ||
| Q1 25 | 12.0% | 4.5% | ||
| Q4 24 | 7.7% | 7.3% | ||
| Q3 24 | 6.9% | 8.1% | ||
| Q2 24 | 9.8% | -1.9% | ||
| Q1 24 | 7.7% | 1.8% |
| Q4 25 | 1.1% | 5.4% | ||
| Q3 25 | 1.2% | 3.8% | ||
| Q2 25 | 1.5% | 4.7% | ||
| Q1 25 | 1.4% | 4.3% | ||
| Q4 24 | 2.2% | 3.8% | ||
| Q3 24 | 2.8% | 3.7% | ||
| Q2 24 | 3.7% | 2.8% | ||
| Q1 24 | 2.2% | 5.5% |
| Q4 25 | — | 1.56× | ||
| Q3 25 | 0.77× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 9.54× | — | ||
| Q2 24 | 6.13× | — | ||
| Q1 24 | 4.70× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AMN
| Travel Nurse Staffing | $208.3M | 28% |
| Allied Staffing | $146.9M | 20% |
| Labor Disruption Services | $124.3M | 17% |
| Technology And Workforce Solutions | $88.0M | 12% |
| Language Services | $69.9M | 9% |
| Other | $29.6M | 4% |
| International Nurse Staffing | $29.6M | 4% |
| Interim Leadership Staffing | $24.1M | 3% |
| Vendor Management Systems | $16.3M | 2% |
| Local Staffing | $8.6M | 1% |
| International Nurse Permanent Placement | $2.6M | 0% |
NTRA
Segment breakdown not available.
